Children With Autism Clinical Trial
— CAACOfficial title:
Computer Assisted Autism Care (CAAC)
Verified date | March 2015 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The investigators hypothesize that children seen in a clinic that uses a compute based system known as CHICA, which reminds pediatricians to screen at defined time point for autism, will be screened more consistently for autism and receive more timely diagnostic a treatment services.
Status | Completed |
Enrollment | 368 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 17 Months to 4 Years |
Eligibility |
Inclusion Criteria: - Previously healthy children receiving routine care in one of four clinics in Indianapolis who participate in this study. Exclusion Criteria: - Previously known autism spectrum disorders or other causes of developmental delay |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening
Country | Name | City | State |
---|---|---|---|
United States | Wishard (Eskenazi) Healthcare clinics | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Structure autism screening instrument administered | Physicians are reminded by the computer system to screen children under 3 years of age for autism with a structured screening instrument. Chart abstraction is used to document whether or not the screening occurred. | Up to 4 years | No |
Secondary | Are appropriate diagnostic studies conducted among children who screen positive for autism. | Among children who a suspected of having autism, chart abstraction and interviews are done to determine if the child received appropriate diagnostic and studies. | Up to 4 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03253081 -
Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response
|
N/A | |
Not yet recruiting |
NCT04246398 -
FMT in Children With Autism and Gastrointestinal Symptoms
|
N/A |